×

Protein modulators of resistance to alkylating agents

  • US 7,875,274 B2
  • Filed: 12/13/2006
  • Issued: 01/25/2011
  • Est. Priority Date: 12/16/2005
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for identifying a therapeutically responsive phenotype in a brain tumor cell, comprising the step of measuring a level of expression of TNFAIP3 gene, NFKBIA gene, TNIP1 gene and TNIP2 genes in the cell and identifying said cell as being sensitive or resistant to an alkylating agent based on said level of expression of TNFAIP3 gene, NFKBIA gene, TNIP1 gene, and TNIP2 genes, wherein a responsive phenotype has more expression of TNIP1, TNFAIP3, NFKBIA and TNIP2 than a resistant phenotype.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×